Long-term clinical efficacy of topical treatment with recombinant human nerve growth factor in neurotrophic keratopathy: a novel cure for a rare degenerative corneal disease?

BACKGROUND: Neurotrophic keratopathy (NK) is a rare, degenerative ocular disease characterized by reduction or loss of corneal sensitivity and development of non-healing corneal epithelial defects and ulcers. Cenegermin, a recombinant human nerve growth factor (rhNGF) eye drop solution, is the first...

Descripción completa

Detalles Bibliográficos
Autores principales: Bruscolini, Alice, Marenco, Marco, Albanese, Giuseppe Maria, Lambiase, Alessandro, Sacchetti, Marta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848655/
https://www.ncbi.nlm.nih.gov/pubmed/35172847
http://dx.doi.org/10.1186/s13023-022-02236-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848655/
https://www.ncbi.nlm.nih.gov/pubmed/35172847
http://dx.doi.org/10.1186/s13023-022-02236-6

Ejemplares similares